{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:55:44Z","timestamp":1795139744873,"version":"4.10.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012533","name":"Minia University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012533","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Recent worldwide reports of increased numbers of multidrug-resistant (MDR)\n                      <jats:italic>Proteus mirabilis<\/jats:italic>\n                      (\n                      <jats:italic>P. mirabilis<\/jats:italic>\n                      ) isolates, particularly those producing extended-spectrum \u03b2-lactamases (ESBLs), are alarming.\n                      <jats:italic>P. mirabilis<\/jats:italic>\n                      is a common causative agent of complicated urinary tract infections (UTIs), particularly in patients with long-term urinary catheterization. This study aimed to assess the prevalence, antibiotic resistance patterns, and determinants of\n                      <jats:italic>P. mirabilis<\/jats:italic>\n                      among catheter-associated UTIs (CAUTI) and non-catheter-associated UTIs (non-CAUTI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      One hundred and three\n                      <jats:italic>Proteus<\/jats:italic>\n                      strains isolated from 613 UTI patients in Minia, Egypt, were examined for antibiotic resistance patterns, ESBL production, and sulphonamide resistance phenotypically. Class 1 and 2 integrons, ESBL, and\n                      <jats:italic>sul<\/jats:italic>\n                      resistance genes were detected by Polymerase chain reaction (PCR), followed by molecular typing of ESBL-producing isolates from catheterized UTI patients using ERIC-PCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Proteus<\/jats:italic>\n                      isolates were detected in 20% of the UTIs, with a higher rate among inpatients (27.3%) compared to outpatients (10.6%).\n                      <jats:italic>Proteus<\/jats:italic>\n                      was more significantly isolated from catheterized UTI patients (28.2%, 55\/195) than from non-catheterized patients (14.9%, 48\/321). Of the 103\n                      <jats:italic>Proteus<\/jats:italic>\n                      isolates, 99 (96.1%) were identified as\n                      <jats:italic>P. mirabilis<\/jats:italic>\n                      . High resistance was observed against trimethoprim\/sulfamethoxazole (SXT) (80.6%), amoxicillin-clavulanic (AMC) (57.3%), ceftazidime (55.3%), and imipenem (46.6%) antibiotics. Significantly higher resistance rates were observed among\n                      <jats:italic>Proteus<\/jats:italic>\n                      isolates from inpatients and catheterized patients. Of the 103\n                      <jats:italic>Proteus<\/jats:italic>\n                      strains, 81 (78.6%) were MDR, with 70.9% of the isolates from catheterized patients. About 74.6% of the isolates from inpatients were MDR.\n                      <jats:italic>Sul<\/jats:italic>\n                      genes were detected in 77 isolates (74.7%). The frequency of ESBL-producing\n                      <jats:italic>Proteus<\/jats:italic>\n                      isolates was 37.9% which was significantly higher in catheterized patients with increasing dissemination of\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>TEM<\/jats:sub>\n                      genes and\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>CTX-M<\/jats:sub>\n                      genes.\n                      <jats:italic>Int1 and Int2<\/jats:italic>\n                      genes were detected in 92.2% and 68.9% of isolates, respectively. ERIC-PCR revealed moderate similarity (65%) between ESBL-producing\n                      <jats:italic>Proteus<\/jats:italic>\n                      isolates from catheterized patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The high frequency of MDR\n                      <jats:italic>P. mirabilis<\/jats:italic>\n                      strains isolated from UTIs in Egypt, particularly among catheterized patients, is a major concern, especially with disseminating class 1 and 2 integrons among isolates. The study also highlights the decreased susceptibility to sulphonamides, 3rd generation cephalosporins, and imipenem, commonly used to treat UTIs. Increased dissemination of ESBL-producing\n                      <jats:italic>Proteus<\/jats:italic>\n                      isolates among CAUTIs complicates their treatments. This important pathogen deserves more attention in the\u00a0future for a better understanding of resistance mechanisms and the\u00a0dissemination potential of resistant strains.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-11118-8","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:47:01Z","timestamp":1748357221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Characterization of antimicrobial resistance among Proteus mirabilis isolates from catheter-associated urinary tract infections and non-catheter-associated urinary tract infections in Egypt"],"prefix":"10.1186","volume":"25","author":[{"given":"Noha A.","family":"Hassuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia N.","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Lami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha S.","family":"Abdelrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"11118_CR1","doi-asserted-by":"publisher","unstructured":"Adeolu M, Alnajar S, Naushad S, S Gupta R. Genome-based phylogeny and taxonomy of the 'Enterobacteriales': proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Int J Syst Evol Microbiol. 2016 Dec;66(12):5575\u20135599. https:\/\/doi.org\/10.1099\/ijsem.0.001485.","DOI":"10.1099\/ijsem.0.001485"},{"issue":"4","key":"11118_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00248-015-0720-6","volume":"72","author":"D Drzewiecka","year":"2016","unstructured":"Drzewiecka D. Significance and Roles of Proteus spp. Bacteria in Natural Environments Microb Ecol. 2016Nov;72(4):741\u201358. https:\/\/doi.org\/10.1007\/s00248-015-0720-6.","journal-title":"Bacteria in Natural Environments Microb Ecol"},{"key":"11118_CR3","doi-asserted-by":"publisher","unstructured":"Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary Tract Infections: The Current Scenario and Future Prospects. Pathogens. 2023;12(4):623. Published 2023 Apr 20. https:\/\/doi.org\/10.3390\/pathogens12040623","DOI":"10.3390\/pathogens12040623"},{"issue":"5\u20136","key":"11118_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000514097","volume":"105","author":"F Yuan","year":"2021","unstructured":"Yuan F, Huang Z, Yang T, Wang G, Li P, Yang B, Li J. Pathogenesis of Proteus mirabilis in Catheter-Associated Urinary Tract Infections. Urol Int. 2021;105(5\u20136):354\u201361. https:\/\/doi.org\/10.1159\/000514097.","journal-title":"Urol Int"},{"key":"11118_CR5","doi-asserted-by":"publisher","unstructured":"Werneburg GT. Catheter-Associated Urinary Tract Infections: Current Challenges and Future Prospects. Res Rep Urol. 2022; 14:109\u2013133. Published 2022 Apr 4. https:\/\/doi.org\/10.2147\/RRU.S273663","DOI":"10.2147\/RRU.S273663"},{"key":"11118_CR6","unstructured":"Centers for disease control and prevention. urinary tract infection (Catheter-Associated Urinary Tract Infection [CAUTI] and non-catheter-associated Urinary Tract Infection [UTI]) Events. National healthcare safety network. 2025. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/7psccauticurrent.pdf."},{"issue":"12","key":"11118_CR7","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.jiph.2021.10.020","volume":"14","author":"TM Uddin","year":"2021","unstructured":"Uddin TM, Chakraborty AJ, Khusro A, et al. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. J Infect Public Health. 2021;14(12):1750\u201366. https:\/\/doi.org\/10.1016\/j.jiph.2021.10.020.","journal-title":"J Infect Public Health"},{"key":"11118_CR8","doi-asserted-by":"publisher","unstructured":"Mirzaei A., Habibi M., Bouzari S., Asadi Karam M. R. Characterization of Antibiotic-Susceptibility Patterns, Virulence Factor Profiles and Clonal Relatedness in Proteus mirabilis Isolates from Patients with Urinary Tract Infection in Iran. Infect Drug Resist. 2019; 12:3967\u20133979. Published 2019 Dec 27. https:\/\/doi.org\/10.2147\/IDR.S230303","DOI":"10.2147\/IDR.S230303"},{"key":"11118_CR9","doi-asserted-by":"publisher","unstructured":"Shaaban, M., Elshaer, S.L. & Abd El-Rahman, O.A. Prevalence of extended-spectrum \u03b2-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates. BMC Microbiol. 2022; 22: 247. https:\/\/doi.org\/10.1186\/s12866-022-02662-3","DOI":"10.1186\/s12866-022-02662-3"},{"key":"11118_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2022.101632","volume":"27","author":"H Vaez","year":"2022","unstructured":"Vaez H, Kalarestaghi H, Sahebkar A, Khademi F. Prevalence of antibiotic resistance of Proteus species in urinary tract infections in Iran: A systematic review and meta-analysis. Gene Reports. 2022;27: 101632. https:\/\/doi.org\/10.1016\/j.genrep.2022.101632.","journal-title":"Gene Reports"},{"key":"11118_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2014\/935842.935842","volume":"2014","author":"D Ojdana","year":"2014","unstructured":"Ojdana D, Sacha P, Wieczorek P, et al. The occurrence of blaCTX-M, blaSHV, and blaTEM genes in extended-spectrum \u03b2-lactamase-positive strains of Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in Poland. International Journal of Antibiotics. 2014;2014:7. https:\/\/doi.org\/10.1155\/2014\/935842.935842.","journal-title":"International Journal of Antibiotics"},{"key":"11118_CR12","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.3389\/fmicb.2018.03332","volume":"9","author":"M S\u00e1nchez-Osuna","year":"2019","unstructured":"S\u00e1nchez-Osuna M, Cort\u00e9s P, Barb\u00e9 J, Erill I. Origin of the mobile di-hydropteroate synthase gene determining sulfonamide resistance in clinical isolates. Front Microbiol. 2019;9:3332. https:\/\/doi.org\/10.3389\/fmicb.2018.03332.","journal-title":"Front Microbiol"},{"key":"11118_CR13","doi-asserted-by":"publisher","unstructured":"Arabi H, Pakzad I, Nasrollahi A, et al. Sulfonamide Resistance Genes (sul) M in Extended Spectrum Beta Lactamase (ESBL) and Non-ESBL Producing Escherichia coli Isolated From Iranian Hospitals. Jundishapur J Microbiol. 2015;8(7):e19961. Published 2015 Jul 25. https:\/\/doi.org\/10.5812\/jjm.19961v2","DOI":"10.5812\/jjm.19961v2"},{"key":"11118_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijantimicag.2017.10.004","volume":"51","author":"M Kaushik","year":"2018","unstructured":"Kaushik M, Kumar S, Kapoor RK, Virdi JS, Gulati P. Integrons in Enterobacteriaceae: Diversity, distribution and epidemiology. Int J Antimicrob Agents. 2018;51:167\u201376. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.10.004.","journal-title":"Int J Antimicrob Agents"},{"key":"11118_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-015-0100-6","volume":"14","author":"Y Deng","year":"2015","unstructured":"Deng Y, Bao X, Ji L, Chen L, Liu J, Miao J, Chen D, Bian H, Li Y, Yu G. Resistance integrons: class 1, 2 and 3 integrons. Ann Clin Microbiol Antimicrob. 2015Dec;14:1\u20131.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"10","key":"11118_CR16","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3390\/diagnostics10100832","volume":"10","author":"N Karah","year":"2020","unstructured":"Karah N, Rafei R, Elamin W, Ghazy A, Abbara A, Hamze M, Uhlin BE. Guideline for urine culture and biochemical identification of bacterial urinary pathogens in low-resource settings. Diagnostics. 2020Oct 16;10(10):832.","journal-title":"Diagnostics"},{"key":"11118_CR17","unstructured":"Tille, Patricia M. author. Bailey & Scott's diagnostic microbiology-E-Book: Elsevier Health Sciences. 2015"},{"key":"11118_CR18","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 33th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute.2023"},{"issue":"3","key":"11118_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"11118_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1128\/aem.46.1.165-170.1983","volume":"46","author":"PH Krumperman","year":"1983","unstructured":"Krumperman PH. Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Appl Environ Microbiol. 1983;46(1):165\u201370. https:\/\/doi.org\/10.1128\/aem.46.1.165-170.1983.","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"11118_CR21","first-page":"117","volume":"41","author":"AA Dashti","year":"2009","unstructured":"Dashti AA, Jadaon MM, Abdulsamad AM, Dashti HM. Heat Treatment of Bacteria: A Simple Method of DNA Extraction for Molecular Techniques. KMJ-Kuwait Medical Journal. 2009;41(2):117\u201322.","journal-title":"KMJ-Kuwait Medical Journal"},{"issue":"6","key":"11118_CR22","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/j.1365-2672.2007.03470.x","volume":"103","author":"Q Li","year":"2007","unstructured":"Li Q, Sherwood JS, Logue CM. Characterization of antimicrobial resistant Escherichia coli isolated from processed bison carcasses. J Appl Microbiol. 2007;103(6):2361\u20139. https:\/\/doi.org\/10.1111\/j.1365-2672.2007.03470.x.","journal-title":"J Appl Microbiol"},{"issue":"1","key":"11118_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/jac\/dki412","volume":"57","author":"N Woodford","year":"2006","unstructured":"Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother. 2006;57(1):154\u20135. https:\/\/doi.org\/10.1093\/jac\/dki412.","journal-title":"J Antimicrob Chemother"},{"issue":"Pt 10","key":"11118_CR24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1099\/jmm.0.016964-0","volume":"59","author":"M Tonki\u0107","year":"2010","unstructured":"Tonki\u0107 M, Mohar B, \u0160i\u0161ko-Kraljevi\u0107 K, et al. High prevalence and molecular characterization of extended-spectrum \u03b2-lactamase-producing Proteus mirabilis strains in southern Croatia. J Med Microbiol. 2010;59(Pt 10):1185\u201390. https:\/\/doi.org\/10.1099\/jmm.0.016964-0.","journal-title":"J Med Microbiol"},{"issue":"2","key":"11118_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.mimet.2005.02.007","volume":"62","author":"B Dillon","year":"2005","unstructured":"Dillon B, Thomas L, Mohmand G, Zelynski A, Iredell J. Multiplex PCR for screening of integrons in bacterial lysates. J Microbiol Methods. 2005;62(2):221\u201332. https:\/\/doi.org\/10.1016\/j.mimet.2005.02.007.","journal-title":"J Microbiol Methods"},{"issue":"5","key":"11118_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1590\/s1413-86702008000500014","volume":"12","author":"L Michelim","year":"2008","unstructured":"Michelim L, Muller G, Zacaria J, Delamare AP, Costa SO, Echeverrigaray S. Comparison of PCR-based molecular markers for the characterization of Proteus mirabilis clinical isolates. Braz J Infect Dis. 2008;12(5):423\u20139. https:\/\/doi.org\/10.1590\/s1413-86702008000500014.","journal-title":"Braz J Infect Dis"},{"key":"11118_CR27","doi-asserted-by":"publisher","unstructured":"Kotb DN, Mahdy WK, Mahmoud MS, Khairy RMM. Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs. BMC Infect Dis. 2019;19(1):979. Published 2019 Nov 21. https:\/\/doi.org\/10.1186\/s12879-019-4606-y","DOI":"10.1186\/s12879-019-4606-y"},{"key":"11118_CR28","doi-asserted-by":"publisher","unstructured":"Salama L., Saleh H., Abdel-Rhman S., Barwa R., Hassa, R. Phenotypic and genotypic characterization of Extended Spectrum \u03b2-lactamases producing Proteus mirabilis isolates. Records of Pharmaceutical and Biomedical Sciences, 2021; 5 (Pharmacognosy-Microbiology): 89\u201399. https:\/\/doi.org\/10.21608\/rpbs.2021.81598.1107","DOI":"10.21608\/rpbs.2021.81598.1107"},{"issue":"1","key":"11118_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.21608\/ejhm.2023.279843","volume":"90","author":"S Al-obaidi","year":"2023","unstructured":"Al-obaidi S, Al-Hashimy A. Molecular Detection of (Urec, Mrpa, Hpma) Genes in Proteus mirabilis Bacteria Isolated from Patients with Urinary Tract Infection. The Egyptian Journal of Hospital Medicine. 2023;90(1):716\u201320. https:\/\/doi.org\/10.21608\/ejhm.2023.279843.","journal-title":"The Egyptian Journal of Hospital Medicine"},{"key":"11118_CR30","doi-asserted-by":"crossref","unstructured":"Mohsin M. R., AL-Rubaii B. A. L. Bacterial growth and antibiotic sensitivity of Proteus mirabilis treated with anti-inflammatory and painkiller drugs. Biomedicine. 2023; 43(02):728\u201334. https:\/\/biomedicineonline.org\/index.php\/home\/article\/view\/2693","DOI":"10.51248\/.v43i02.2693"},{"key":"11118_CR31","doi-asserted-by":"publisher","unstructured":"El-Kazzaz S. Virulence Factors Associated with Quinolone Resistance in Proteus Species Isolated from Patients with Urinary Tract Infection. Egyptian Journal of Medical Microbiology, 2021; 30(1): 115\u2013123. https:\/\/doi.org\/10.51429\/EJMM30115","DOI":"10.51429\/EJMM30115"},{"issue":"4","key":"11118_CR32","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.4314\/ahs.v21i4.22","volume":"21","author":"A Tabatabaei","year":"2021","unstructured":"Tabatabaei A, Ahmadi K, Shabestari AN, Khosravi N, Badamchi A. Virulence genes and antimicrobial resistance pattern in Proteus mirabilis strains isolated from patients attended with urinary infections to Tertiary Hospitals. Iran Afr Health Sci. 2021;21(4):1677\u201384. https:\/\/doi.org\/10.4314\/ahs.v21i4.22.","journal-title":"Iran Afr Health Sci"},{"key":"11118_CR33","doi-asserted-by":"publisher","unstructured":"Danilo de Oliveira W, Lopes Barboza MG, Faustino G, et al. Virulence, resistance and clonality of Proteus mirabilis isolated from patients with community-acquired urinary tract infection (CA-UTI) in Brazil. Microb Pathog. 2021; 152:104642. https:\/\/doi.org\/10.1016\/j.micpath.2020.104642","DOI":"10.1016\/j.micpath.2020.104642"},{"key":"11118_CR34","doi-asserted-by":"publisher","unstructured":"G. Ali, D., F. M. Gad, G., A. O. Ismail, O., R. Ahmed, H., A. Ibrahem, R. Prevalence and characterization of plasmid-mediated quinolone resistance genes in Proteus species isolated from different patients. Novel Research in Microbiology Journal, 2023; 7(3): 1966\u20131981. https:\/\/doi.org\/10.21608\/nrmj.2023.300633","DOI":"10.21608\/nrmj.2023.300633"},{"key":"11118_CR35","doi-asserted-by":"publisher","unstructured":"Mirzaei A, Nasr Esfahani B, Raz A, Ghanadian M, Moghim S. From the Urinary Catheter to the Prevalence of Three Classes of Integrons,\u00a0\u03b2-Lactamase Genes, and Differences in Antimicrobial Susceptibility of\u00a0Proteus mirabilis\u00a0and Clonal Relatedness with Rep-PCR.\u00a0Biomed Res Int. 2021; 2021:9952769. Published 2021 Jun 10. https:\/\/doi.org\/10.1155\/2021\/9952769","DOI":"10.1155\/2021\/9952769"},{"issue":"3","key":"11118_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.26502\/acbr.50170257","volume":"6","author":"NJ Mishu","year":"2022","unstructured":"Mishu NJ, Shamsuzzaman S, Khaleduzzaman H, Nabonee MA. Association between Biofilm Formation and Virulence Genes Expression and Antibiotic Resistance Pattern in Proteus mirabilis, Isolated from Patients of Dhaka Medical College Hospital. Arch Clin Biomed Res. 2022;6(3):418\u201334. https:\/\/doi.org\/10.26502\/acbr.50170257.","journal-title":"Arch Clin Biomed Res"},{"key":"11118_CR37","doi-asserted-by":"publisher","unstructured":"D'Incau S, Atkinson A, Leitner L, Kronenberg A, Kessler TM, Marschall J. Bacterial species and antimicrobial resistance differ between catheter and non-catheter-associated urinary tract infections: Data from a national surveillance network. Antimicrob Steward Healthc Epidemiol. 2023;3(1): e55. Published 2023 Mar 20. https:\/\/doi.org\/10.1017\/ash.2022.340.","DOI":"10.1017\/ash.2022.340"},{"key":"11118_CR38","doi-asserted-by":"publisher","unstructured":"Sharma S, Mohler J, Mahajan SD, Schwartz SA, Bruggemann L, Aalinkeel R. Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment. Microorganisms. 2023;11(6):1614. Published 2023 Jun 19. https:\/\/doi.org\/10.3390\/microorganisms11061614","DOI":"10.3390\/microorganisms11061614"},{"key":"11118_CR39","doi-asserted-by":"publisher","unstructured":"Priya PS, Manonmoney, Leela KV. Phenotypic Characterisation of\u00a0Proteus Species\u00a0Isolated from Different Clinical Samples with Special Reference to Antibiotic Resistance Pattern in a Tertiary Care Centre. J Clin of Diagn Res. 2022;\u00a016(1): DC15-DC19.\u00a0https:\/\/doi.org\/10.7860\/JCDR\/2022\/51928.15901","DOI":"10.7860\/JCDR\/2022\/51928.15901"},{"key":"11118_CR40","doi-asserted-by":"publisher","unstructured":"Mohamed ES, Khairy RMM, Abdelrahim SS. Prevalence and molecular characteristics of ESBL and AmpC \u03b2 -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt. Antimicrob Resist Infect Control. 2020;9(1):198. Published 2020 Dec 10. https:\/\/doi.org\/10.1186\/s13756-020-00856-w","DOI":"10.1186\/s13756-020-00856-w"},{"key":"11118_CR41","doi-asserted-by":"publisher","unstructured":"Ahn JY, Ann HW, Jeon Y, et al. The impact of production of extended-spectrum \u03b2-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea. BMC Infect Dis. 2017;17(1):327. Published 2017 May 3. https:\/\/doi.org\/10.1186\/s12879-017-2431-8","DOI":"10.1186\/s12879-017-2431-8"},{"key":"11118_CR42","doi-asserted-by":"publisher","unstructured":"Sokhn ES, Salami A, El Roz A, Salloum L, Bahmad HF, Ghssein G. Antimicrobial Susceptibilities and Laboratory Profiles of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates as Agents of Urinary Tract Infection in Lebanon: Paving the Way for Better Diagnostics. Med Sci (Basel). 2020;8(3):32. Published 2020 Aug 13. https:\/\/doi.org\/10.3390\/medsci8030032","DOI":"10.3390\/medsci8030032"},{"issue":"2","key":"11118_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4314\/ahs.v17i2.9","volume":"17","author":"OS Alabi","year":"2017","unstructured":"Alabi OS, Mendon\u00e7a N, Adeleke OE, da Silva GJ. Molecular screening of antibiotic-resistant determinants among multidrug-resistant clinical isolates of Proteus mirabilis from SouthWest Nigeria. Afr Health Sci. 2017;17(2):356\u201365. https:\/\/doi.org\/10.4314\/ahs.v17i2.9.","journal-title":"Afr Health Sci"},{"key":"11118_CR44","doi-asserted-by":"publisher","unstructured":"Obadire, S., Obadire, F., Mitsan, O., Odeyinka, O., Ugbomoiko, D., Ilesanmi, I., Olakunle, O. Distribution of resistance genes encoding Extended Spectrum Beta-Lactamase (ESBL) in Proteus mirabilis species isolated from selected Hospitals in Jigawa State, Nigeria. Microbes and Infectious Diseases, 2023; (): -. https:\/\/doi.org\/10.21608\/mid.2023.215024.1533","DOI":"10.21608\/mid.2023.215024.1533"},{"issue":"10","key":"11118_CR45","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fmicb.2019.00790","volume":"24","author":"L Xiao","year":"2019","unstructured":"Xiao L, Wang X, Kong N, Cao M, Zhang L, Wei Q, Liu W. Polymorphisms of Gene Cassette Promoters of the Class 1 Integron in Clinical Proteus Isolates. Front Microbiol. 2019Apr;24(10):790. https:\/\/doi.org\/10.3389\/fmicb.2019.00790.","journal-title":"Front Microbiol"},{"issue":"5","key":"11118_CR46","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1111\/jam.15738","volume":"133","author":"VK Deekshit","year":"2022","unstructured":"Deekshit VK, Srikumar S. \u2019To be, or not to be\u2019-The dilemma of \u201csilent\u201d antimicrobial resistance genes in bacteria. J Appl Microbiol. 2022;133(5):2902\u201314. https:\/\/doi.org\/10.1111\/jam.15738.","journal-title":"J Appl Microbiol"},{"issue":"1","key":"11118_CR47","first-page":"182","volume":"4","author":"A Elsheredy","year":"2023","unstructured":"Elsheredy A, Faisal E, El Sherbini E, Attia N. Coexistence of integrons class 1 and 2 with emergence of class 3 among Proteus mirabilis clinical isolates from Alexandria. Egypt Microbes and Infectious Diseases. 2023Feb 1;4(1):182\u201393.","journal-title":"Egypt Microbes and Infectious Diseases"},{"key":"11118_CR48","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2147\/IDR.S347119","volume":"1","author":"W Lu","year":"2022","unstructured":"Lu W, Qiu Q, Chen K, Zhao R, Li Q, Wu Q. Distribution and molecular characterization of functional class 2 integrons in clinical Proteus mirabilis isolates. Infection and drug resistance. 2022Jan;1:465\u201374.","journal-title":"Infection and drug resistance"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11118-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11118-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11118-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:47:04Z","timestamp":1748357224000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11118-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11118"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11118-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Research Ethics Committee, Minia University, Faculty of Medicine Institutional Review Board (MUFMIRB Approval No. 276:2\/2022). MUFMIRB operates according to the guidelines of the Declaration of Helsinki and CIOMS (Council for International Organizations of Medical Sciences). Informed consents were obtained from all participants in the study for the use of the samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"767"}}